Core Viewpoint - The company, Lino Pharmaceutical, announced the full redemption of its convertible bonds at a price of 100.55 yuan per bond on March 13, 2026, with a registration date for redemption set for March 12, 2026 [1] Summary by Relevant Sections - **Redemption Details** - The company will redeem all "Lino Convertible Bonds" at a price of 100.55 yuan per bond [1] - The redemption registration date is March 12, 2026, and trading will stop on March 10, 2026 [1] - Holders who do not convert their bonds within the specified period will be forced to redeem them [1] - **Conversion Conditions** - To convert the bonds, holders must have trading permissions for the ChiNext market [1]

Group 1 - The core point of the article highlights that the last trading day for Sailong Convertible Bonds is February 27, with a market price of 131.11 CNY per bond, while the redemption price is 100.33 CNY, indicating a potential loss of 23.48% for investors who do not act in time [2][8] - The announcement from Juhua Long indicates that investors can still convert their bonds into stocks until the market closes on March 4, after which unconverted bonds will be forcibly redeemed at 100.33 CNY per bond [4][7] - As of February 27, 31.92% of Sailong Convertible Bonds remain unconverted, with a total bond balance of 0.8 billion CNY [8] Group 2 - Several other convertible bonds are also facing forced redemption, including Shouhua, Tianjian, Guanglian, Feng21, Linuo, and Xinfeng bonds, with last trading days ranging from March 2 to March 11 and varying redemption prices [10] - Investors holding these convertible bonds may face significant losses if they do not sell or convert in time, with potential losses ranging from 11.14% to 38.69% depending on the specific bond [10] - It is noted that investors can sell their convertible bonds on the last trading day due to T+0 trading rules, or they can convert them into stocks, which will then follow T+1 trading rules [10]

Core Viewpoint - Lino Pharmaceutical announced a mandatory redemption of its convertible bonds at a price of 100.55 yuan per bond, effective after the market closes on March 12, 2026, due to a significant discrepancy between the market price and the redemption price [1] Group 1 - The company has issued a reminder to holders of Lino convertible bonds to convert their bonds within the specified period to avoid potential losses [1] - The current market price of Lino convertible bonds is considerably lower than the redemption price, indicating a potential investment risk for bondholders [1]

Group 1 - Tongwei Co., Ltd. is planning to acquire 100% equity of Lihua Qingneng, leading to a stock suspension [1] - The acquisition is part of Tongwei's strategy to expand its business operations [1] Group 2 - Runda Medical's shareholders plan to reduce their holdings by no more than 2.99% [5] - Li Qun Convertible Bond has its last trading day before maturity set for March 26, 2026 [5] - Jia Yuan Convertible Bond is subject to forced redemption [5] - Youfa and Youcai Convertible Bonds are not subject to forced redemption [5] - Blue Fan Convertible Bond has proposed a down adjustment [5] Group 3 - Various convertible bonds are listed with their current prices, conversion values, and remaining scales, indicating market performance [4][7]

Group 1 - The company Lino Pharmaceutical announced the completion of the redemption of "Lino Convertible Bonds," which will be delisted from the Shenzhen Stock Exchange [2] - Bondholders are advised to lift any pledges or freezes on their "Lino Convertible Bonds" before the conversion deadline to avoid being forced to redeem due to inability to convert [2] - Investors must open a ChiNext trading account to convert their "Lino Convertible Bonds" into stocks, and those who do not meet the suitability requirements cannot convert their bonds [2] Group 2 - As of March 12, 2026, any "Lino Convertible Bonds" that have not been converted will be forcibly redeemed at a price of 100.55 yuan per bond [2] - There is a significant difference between the current secondary market price of "Lino Convertible Bonds" and the redemption price, highlighting the importance for bondholders to convert in a timely manner to avoid potential losses [2]

Group 1 - The company, Lino Pharmaceutical, announced the early redemption of its convertible bonds at a price of 100.55 yuan per bond, including interest and tax [2] - The redemption registration date is set for March 12, 2026, with the actual redemption occurring on March 13, 2026 [2] - Trading of the bonds will cease on March 10, 2026, and conversion rights will be suspended starting March 13, 2026, with any unconverted bonds being forcibly redeemed and delisted [2]

Group 1 - The core announcement from Lino Pharmaceutical indicates that as of March 12, 2026, any unconverted "Lino Convertible Bonds" will be forcibly redeemed at a price of 100.55 CNY per bond [2] - The current secondary market price of "Lino Convertible Bonds" significantly differs from the redemption price, prompting a warning to bondholders to convert their bonds within the specified timeframe [2] - Investors who fail to convert their bonds in time may face potential losses, highlighting the importance of timely action for bondholders [2]

Group 1 - The core index of convertible bonds, the Zhongzheng Convertible Bond Index, rose by 0.46% to 528.80 points on February 12 [1] - Notable gainers included N Longjian Convertible Bond, Yubang Convertible Bond, Yingliu Convertible Bond, Zhenhua Convertible Bond, and Aofei Convertible Bond, with increases of 30.00%, 10.85%, 7.80%, 6.40%, and 6.30% respectively [1] - Conversely, Baichuan Convertible Bond 2, Linuo Convertible Bond, Huayang Convertible Bond, Huicheng Convertible Bond, and Tianchuang Convertible Bond experienced significant declines, with drops of 7.94%, 5.23%, 3.75%, 3.22%, and 3.19% respectively [1]

Core Viewpoint - The article discusses recent developments in convertible bonds, including price adjustments, strong redemptions, and new listings, highlighting the dynamics of the convertible bond market [1][4][6]. Group 1: Convertible Bond Adjustments - Longda Convertible Bond's conversion price has been adjusted down to 4.2 yuan [1]. - Xinfeng and Linuo Convertible Bonds are subject to strong redemption [1]. - Yubang Convertible Bond will not undergo strong redemption [1]. - Wanquan Convertible Bond will not have its price adjusted [1]. Group 2: Market Data on Convertible Bonds - The current price of Beigang Convertible Bond is 132.518, with a strong redemption price of 101.130 and a remaining scale of 0.226 billion [4]. - Shentong Convertible Bond has a current price of 123.250, with a strong redemption price of 100.445 and a remaining scale of 0.020 billion [4]. - Huazheng Convertible Bond is priced at 194.075, with a strong redemption price of 100.153 and a remaining scale of 0.058 billion [4]. - The current price of Xingfa Convertible Bond is 135.723, with a strong redemption price of 100.670 and a remaining scale of 13.238 billion [4]. Group 3: New Listings and Other Developments - Haisheng Medical has recently listed on the Beijing Stock Exchange [1]. - Reports indicate that small amounts of redemption funds for Zhongzhuang Convertible Bond have been received by investors [1].

Core Viewpoint - The company, Lino Pharmaceutical Packaging, announced that its stock price has remained above 130% of the conversion price of its convertible bonds for ten consecutive trading days, potentially triggering a conditional redemption clause for the bonds [1] Group 1 - As of January 28, 2026, the company's stock price has closed at or above 18.46 CNY per share, which is 130% of the current conversion price of the convertible bonds [1] - If the stock price continues to meet this threshold, the company may consider redeeming the outstanding convertible bonds at face value plus accrued interest [1] - The board of directors will convene to decide on the redemption of all or part of the unconverted convertible bonds if the conditions are met [1]